Skip to content

Doximity DOCS Warrants and Rights Outstanding

Warrants and Rights Outstanding at other companies

KEE
Keel Infrastructure Corp. Common StockKEEL
2.2M
NuScale Power logo
NuScale PowerSMR
0-100%
Calumet, Inc. logo
Calumet, Inc.CLMT
$7.8M0.0%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
312.5K0.0%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
500K
JAN
Janus Living JAN
20M

Other financials

Income statement

See full
Revenue$145.4M+5.1%
Gross profit$126.0M+1.7%
Operating income$24.8M-49.0%
Net income$19.1M-69.4%
EPS (diluted)$0.10-67.7%

Balance sheet

See full
Cash & equivalents$219.2M+4.6%
Total debt$10.2M-17.8%
Total equity$950.8M-12.2%
Total assets$1.1B-11.1%

Cash flow

See full
Operating cash flow$109.5M+11.2%
CapEx-
Free cash flow$81.6M-17.1%

Valuation

See full
Market cap$3.75B-60.5%

Profitability

See full
Gross margin89.1%-1.1pp
Operating margin33.3%-6.6pp
Net margin30.4%-8.7pp
FCF margin50.6%+2.7pp

Returns & leverage

See full
Return on equity19.3%-3.2pp
Debt / equity0.0×
Current ratio6.1×-0.9×

Where this comes from

Reported directly by Doximity in its filing.

Tagged under the XBRL concept us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.

The official record: Doximity’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Doximity's warrants and rights outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Doximity's warrants and rights outstanding?
Doximity (DOCS) reported warrants and rights outstanding of 229K in Q4 2025.
How has Doximity's warrants and rights outstanding changed year-over-year?
Doximity's warrants and rights outstanding decreased by 27.3% year-over-year, from 315K to 229K.